Skip to main content
Clinical Trials/CTRI/2024/06/068819
CTRI/2024/06/068819Not yet recruitingPhase 3

Antibacterial efficacy of combined zinc nanoparticles-calcium hydroxide root canal medication in healthy and diabetic patients with apical periodontitis - A case-control study - NI

Shaima Misbah Shafiq0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Patients with controlled type 2 diabetes (HbA1c level is 6.5% or below)having non-vital teeth with apical periodontitis
  • Radiographic evidence of apical periodontitis (PAI score: 2-5)

Exclusion Criteria

  • Systemic factors such as pregnancy, and other co-existing immunocompromised conditions that can impair healing.
  • Previously endodontically treated teeth
  • Teeth with gross carious lesions (unrestorable), root fractures, open apex, intraoral and extraoral swelling, and extraoral sinus opening.
  • Cases showing periodontal pockets deeper than 4 mm.
  • Patients on antibiotic medications within 3 previous months.

Investigators

Sponsor
Shaima Misbah Shafiq

Similar Trials